BHC Bausch Health Companies Inc.
Healthcare$5.38+0.00%OpenMarket Cap: $2.01B
As of 2026-05-26
Valuation
P/E (TTM)
13.36
PEG
0.03
P/B
-0.99
P/S
0.19
EV/EBITDA
5.95
DCF Value
$182.27
FCF Yield
48.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.7%
Operating Margin
22.9%
Net Margin
-11.3%
ROE
120.7%
ROA
-4.9%
ROIC
11.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.49B | 61.2% | $513.8M | $-1.40B | $— | — |
| Q4 null | $2.84B | 63.0% | $730.1M | $-113.7M | $— | — |
| FY null | $10.45B | 60.9% | $2.22B | $159.7M | $— | — |
| Q3 null | $2.65B | 62.6% | $709.0M | $177.0M | $— | — |
| Q2 null | $2.57B | 59.7% | $464.8M | $150.5M | $— | — |
| Q1 null | $2.25B | 57.6% | $291.1M | $-57.8M | $— | — |
| Q4 null | $2.56B | 71.6% | $558.0M | $93.0M | $— | — |
| FY null | $9.63B | 71.1% | $1.55B | $-46.0M | $— | — |
| Q3 null | $2.51B | 72.3% | $318.0M | $-85.0M | $— | — |
| Q2 null | $2.40B | 70.1% | $389.0M | $10.0M | $— | — |
| Q1 null | $2.15B | 70.3% | $281.0M | $-63.7M | $— | — |
| Q4 2023 | $2.41B | 70.7% | $362.0M | $-39.0M | $-0.11 | — |